⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HRTX News
Heron Therapeutics, Inc.
Form 8-K
sec.gov
HRTX
U.S. District Court Issues Decision Regarding CINVANTI® Patents
globenewswire.com
HRTX
Form 8-K
sec.gov
HRTX
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
globenewswire.com
HRTX
Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026
globenewswire.com
HRTX
Cedar Expands AI-Powered Personalization in Healthcare Billing With New Cedar Intelligence Capabilities
prnewswire.com
HRTX
Form 8-K
sec.gov
HRTX
Form 8-K
sec.gov
HRTX
Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results
globenewswire.com
HRTX
Chemotherapy Induced Peripheral Neuropathy (CIPN) Treatment Market Report 2026-2032: Revenues to Grow by $750M at 8.64% CAGR
globenewswire.com
ABBV
AMGN
PFE
BMY
MRK
REGN
SNY
TAK
NVS
GSK
HRTX